MedTrace Logo

Retrospective Study of Patients Undergoing Percutaneous Intervention of the Transplant Renal Artery Stenosis

NCT04225338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 313

Last updated 2020-01-13

No results posted yet for this study

Summary

Renal transplantation is the standard treatment for patients with end-stage chronic kidney disease because it is effective in reducing the morbidity and mortality. Despite of the satisfactory results, some patients evolve with graft dysfunction and refractory hypertension due to transplanted renal artery stenosis (TRAS). TRAS is the main vascular complication of patients undergoing kidney transplantation, with a reported incidence ranging 1 to 23% in the different series in the literature, depending on the definition and diagnostic techniques used, manifesting most commonly between the 3rd month and the 2nd year after transplantation.

Percutaneous intervention of TRAS is widely accepted as a viable treatment option, but there are few long-term data on patients undergoing angioplasty. The aim of this study was to evaluate long term outcomes clinical in patients with TRAS underwent to percutaneous intervention with or without stent.

Conditions

  • Transplant Renal Artery Stenosis

Sponsors & Collaborators

  • Adriano Henrique Pereira Barbosa

    lead OTHER

Principal Investigators

  • Adriano HP Barbosa, MDPhD · Unifesp/EPM

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-02
Primary Completion
2019-02-01
Completion
2019-02-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04225338 on ClinicalTrials.gov